Founders Financial Securities’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $527K | Buy |
4,752
+1,848
| +64% | +$205K | 0.04% | 336 |
|
|
2025
Q1 | $309K | Sell |
2,904
-7,101
| -71% | -$755K | 0.03% | 391 |
|
|
2024
Q4 | $924K | Sell |
10,005
-2,279
| -19% | -$211K | 0.08% | 190 |
|
|
2024
Q3 | $1.03M | Buy |
12,284
+39
| +0.3% | +$3.27K | 0.1% | 182 |
|
|
2024
Q2 | $840K | Buy |
12,245
+413
| +3% | +$28.3K | 0.08% | 204 |
|
|
2024
Q1 | $867K | Buy |
11,832
+833
| +8% | +$61K | 0.09% | 184 |
|
|
2023
Q4 | $891K | Buy |
10,999
+1,668
| +18% | +$135K | 0.1% | 179 |
|
|
2023
Q3 | $699K | Buy |
+9,331
| New | +$699K | 0.09% | 172 |
|
|
2023
Q2 | – | Sell |
-2,588
| Closed | -$215K | – | 328 |
|
|
2023
Q1 | $215K | Buy |
2,588
+84
| +3% | +$6.97K | 0.03% | 295 |
|
|
2022
Q4 | $215K | Buy |
+2,504
| New | +$215K | 0.03% | 297 |
|
|
2017
Q3 | – | Sell |
-13,652
| Closed | -$966K | – | 95 |
|
|
2017
Q2 | $966K | Sell |
13,652
-91
| -0.7% | -$6.44K | 0.37% | 39 |
|
|
2017
Q1 | $933K | Buy |
13,743
+3,099
| +29% | +$210K | 0.35% | 47 |
|
|
2016
Q4 | $762K | Sell |
10,644
-35
| -0.3% | -$2.51K | 0.32% | 38 |
|
|
2016
Q3 | $845K | Buy |
+10,679
| New | +$845K | 0.36% | 41 |
|